Quick Answer
Opus Genetics, Inc. reported Net Income of -$49.59 million for fiscal year 2025.
Opus Genetics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$49.59M | +13.8% |
| 2024 | -$57.53M | -476.1% |
| 2023 | -$9.99M | -155.8% |
| 2022 | $17.89M | +131.6% |
| 2021 | -$56.69M | -130.3% |
| 2020 | -$24.62M | -299.1% |
| 2019 | -$6.17M | +57.1% |
| 2018 | -$14.37M | +43.2% |
| 2017 | -$25.29M | -171.8% |
| 2016 | -$9.31M | +35.3% |
| 2015 | -$14.38M | +22.3% |
| 2014 | -$18.52M | -95.0% |
| 2013 | -$9.50M | -52.6% |
| 2012 | -$6.23M | +45.1% |
| 2011 | -$11.34M | +19.1% |
| 2010 | -$14.02M | -383.0% |
| 2009 | -$2.90M | +21.2% |
| 2008 | -$3.68M | +17.1% |
| 2007 | -$4.44M | +31.5% |
| 2006 | -$6.49M | -2.1% |
| 2005 | -$6.35M | -94.0% |
| 2004 | -$3.27M | -18.0% |
| 2003 | -$2.78M | -134.9% |
| 2002 | -$1.18M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.45M | -131.9% | -135.2% |
| June 30, 2025 | -$7.42M | +4.4% | +9.4% |
| March 31, 2025 | -$8.19M | -15.3% | -8.9% |
| September 30, 2024 | -$7.53M | -235.3% | +3.1% |
| June 30, 2024 | -$7.76M | -56.5% | -9.3% |
| March 31, 2024 | -$7.11M | -22.7% | -227.8% |
| September 30, 2023 | $5.56M | +222.7% | +212.1% |
| June 30, 2023 | -$4.96M | -0.7% | +14.3% |
- Opus Genetics, Inc. showed an increase of +13.8% in Net Income compared to the prior fiscal year.
- Over the 2002–2025 period, Opus Genetics, Inc.’s net income has declined by 4098.5% (from -$1.18 million to -$49.59 million).
- The most recent figure is from Opus Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: